Last reviewed · How we verify
VV119
At a glance
| Generic name | VV119 |
|---|---|
| Sponsor | Vigonvita Life Sciences |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Food Effects of VV119 Capsules in Chinese Healthy Volunteers (PHASE1)
- Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119 (PHASE1)
- Study of the Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Chinese Healthy Volunteers (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- VV119 CI brief — competitive landscape report
- VV119 updates RSS · CI watch RSS
- Vigonvita Life Sciences portfolio CI